Immobilized human PD-1 at 0.5 μg/ml (50 μL/well) can bind to Nivolumab with a linear range of 0.305 ng/ml-5 μg/ml.
Anti-PD-1 Monoclonal Antibody(Nivolumab)
Anti-PD-1 Monoclonal Antibody(Nivolumab)
Price:
Regular price
$336.00 SGD
Regular price
Sale price
$336.00 SGD
Unit price
per
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details
Product Details
Product Details
Product Specification
| Host | Human |
| Antigen | PD-1 |
| Synonyms | Programmed cell death protein 1, Protein PD-1, hPD-1, CD279, PDCD1 |
| Accession | Q15116 |
| Clone Number | S-SC016 |
| Antibody Type | Recombinant mAb |
| Isotype | IgG4,k |
| Application | Blocking of PD-1/PD-L signaling Functional assays |
| Purification | Protein A |
| Concentration | 2 mg/ml |
| Endotoxin | <1EU/mg |
| Conjugation | Unconjugated |
| Physical Appearance | Liquid |
| Storage Buffer | PBS pH7.4, containing no preservative |
| Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution
| application | dilution | species |
| ELISA | 0.305-5000 ng/ml |
Background
Nivolumab is a type of targeted therapy drug called an immune checkpoint inhibitor (a type of immunotherapy). It is a monoclonal antibody that binds to the protein PD-1 on the surface of immune cells called T cells. It works by keeping cancer cells from suppressing the immune system. This allows the immune system to attack and kill the cancer cells.
Picture
Picture
ELISA
